Monday - December 23, 2024

T Cell Activating Bispecific Antigen Binding Molecules

2024-11-12

ALEXANDRIA, Virginia, Nov. 12 -- HOFFMANN-LA ROCHE INC., Little Falls, New Jersey has been assigned a patent (No. US 12139553 B2, initially filed Jan. 20, 2022) developed by eight inventors Marina Bacac, Zurich, Switzerland; Peter Bruenker, Hittnau, Switzerland; Anne Freimoser-Grundschober, Zurich, Switzerland; Ralf Hosse, Cham, Switzerland; Christian Klein, Bonstetten, Switzerland; Ekkehard Moessner, Kreuzlingen, Switzerland; Pablo Umana, Wollerau, Switzerland; and Tina Weinzierl, Schlieren, S . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

T Cell Activating Bispecific Antigen Binding Molecules

Information Request Form

Copyright Targeted News Service 2024